Cargando…
Access to innovative oncology medicines in Europe
The incidence of cancer will increase within the next 5 years up to 15 million patients per year worldwide with a further increasing tendency. Therefore, there is a requirement for more emphasis on cancer prevention, research and effective anticancer drugs including a rapid licensing and market avai...
Autores principales: | Bergmann, L., Enzmann, H., Thirstrup, S., Schweim, J. K., Widera, I., Zwierzina, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722892/ https://www.ncbi.nlm.nih.gov/pubmed/26578739 http://dx.doi.org/10.1093/annonc/mdv547 |
Ejemplares similares
-
More Symmetrical Children Have Faster and More Consistent Choice Reaction Times
por: Hope, David, et al.
Publicado: (2015) -
Personalized medicine: Striding from genes to medicines
por: Nair, Sunita R.
Publicado: (2010) -
Discordance Between Child‐Pugh and National Cancer Institute Classifications for Hepatic Dysfunction: Implications on Dosing Recommendations for Oncology Compounds
por: Elmeliegy, Mohamed, et al.
Publicado: (2020) -
The Cardiovascular Effects of a Meal: J‐T(peak) and T(peak)‐T(end) Assessment and Further Insights Into the Physiological Effects
por: Täubel, Jörg, et al.
Publicado: (2019) -
Diabetes mellitus: Exploring the challenges in the drug development process
por: Vaz, Julius A., et al.
Publicado: (2012)